The Enigma of Rapamycin Dosage.

Mukhopadhyay S, Frias MA, Chatterjee A, Yellen P, Foster DA. The Enigma of Rapamycin Dosage. Mol Cancer Ther. 2016 Mar; 15(3):347-53.

View in: PubMed

subject areas

Animals
Antibiotics, Antineoplastic
Antineoplastic Combined Chemotherapy Protocols
Cell Line, Tumor
Drug Resistance, Neoplasm
Humans
Multiprotein Complexes
Neoplasms
Protein Binding
Protein Kinase Inhibitors
Signal Transduction
Sirolimus

authors with profiles

David A. Foster

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support